In the 1950s, C-reactive protein (CRP) was first identified as an inflammatory biomarker for acute myocardial infarction (AMI), and decades later, it was also shown to be associated with cardiac hypertrophy and failure (3–7). The gene discussed is CRP; the disease is cardiac hypertrophy.